Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Harvard Business School
AstraZeneca
Baxter
Merck

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Miles Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for MILES, and what generic and branded alternatives to MILES drugs are available?

MILES has sixteen approved drugs.



Summary for Miles
US Patents:0
Tradenames:18
Ingredients:11
NDAs:16
Patent Litigation for Miles: See patent lawsuits for Miles

Drugs and US Patents for Miles

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Miles STERILE WATER IN PLASTIC CONTAINER sterile water for irrigation LIQUID;IRRIGATION 018246-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Miles DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 018501-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Miles DEXTROSE 10% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 018504-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Miles DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 018500-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Miles DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 018499-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Miles SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 018502-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Miles POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 080195-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Baxter
AstraZeneca
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.